Aztreonam
Edina Avdic, Pharm.D.
,
Paul A. Pham, Pharm.D.
Pediatric Dosing Author:
Alice Jenh Hsu, PharmD, BCPS, AQ-ID
INDICATIONS
INDICATIONS
INDICATIONS
FDA
FDA
FDA
Gram-negative bacterial pneumonia
Skin and soft tissue infections (caused by Gram-negative bacilli)
Complicated
and
uncomplicated urinary tract infections
Intra-abdominal infections
(in combination with
metronidazole
)
Septicemia (cause by Gram-negative bacilli)
Gynecologic infections (in combination with anaerobic coverage)
Nebulized aztreonam is indicated for treatment of respiratory symptoms in cystic fibrosis (CF patients with FEV1 of 25-75% of predicted) with
P. aeruginosa
NON-FDA APPROVED USES
NON-FDA APPROVED USES
NON-FDA APPROVED USES
Alternative therapy for treatment of Gram-negative infections in patients with severe allergies
There's more to see -- the rest of this topic is available only to subscribers.
© 2000–2025 Unbound Medicine, Inc. All rights reserved